Infectious Disease and Microbiology – Kluyvera Species

Overview

Kluyvera species are Gram-negative bacilli within the Enterobacterales that are uncommon causes of human infection. They have a worldwide distribution and may colonize humans without producing disease.

When infection occurs, it is often opportunistic or endogenous and may present as bacteremia, urinary tract infection, soft-tissue infection, or pneumonia, particularly in immunocompromised patients.

Important Species

The source lists:

• Kluyvera ascorbata

• Kluyvera cryocrescens

The source spelling “K. cryorencens” appears to be an error; the recognized species name is:

Kluyvera cryocrescens

Microbiologic Characteristics

Kluyvera species are:

• Gram-negative bacilli

• Facultatively anaerobic members of Enterobacterales

• Generally motile

• Opportunistic pathogens

• Uncommon causes of clinically significant infection

Older references may describe them simply as aerobic Gram-negative bacilli.

Incubation Period

A specific incubation period is generally not applicable because infection is usually:

Endogenous

Disease may develop when colonizing organisms enter normally sterile sites, particularly in patients with disrupted host defenses.

Epidemiology

Kluyvera species have a:

Worldwide distribution

However, clinically significant infection is:

Rare

Isolation therefore requires interpretation in the context of the patient’s symptoms, specimen source, and underlying risk factors.

Opportunistic Infection

Kluyvera behaves primarily as an opportunistic pathogen.

Infection is more likely in patients with:

• Immunosuppression

• Serious underlying illness

• Prolonged hospitalization

• Invasive devices

• Disruption of normal anatomic barriers

Nevertheless, infections can occasionally occur in otherwise healthy individuals.

Bacteremia

Kluyvera species can cause:

Bacteremia

Bloodstream infection may arise from another focus such as the:

• Urinary tract

• Soft tissues

• Respiratory tract

Severe cases may progress to systemic sepsis.

High-Yield Bacteremia Pattern

Hospitalized or immunocompromised patient

• ●

Unusual Enterobacterales isolated from blood

• ●

Possible urinary or soft-tissue source

→ Consider Kluyvera species

Urinary Tract Infection

Kluyvera species have been associated with:

Urinary tract infections

Clinical presentations may include:

• Cystitis

• Pyelonephritis

• Complicated urinary infection

• Urosepsis

Urine culture with susceptibility testing is important because antimicrobial resistance patterns may vary.

Soft-Tissue Infection

The organisms can occasionally produce:

Skin and soft-tissue infection

Potential manifestations include:

• Wound infection

• Cellulitis

• Abscess formation

Management may require both appropriate antimicrobial therapy and source control, such as drainage or debridement when indicated.

Pneumonia

The source particularly associates Kluyvera with:

Pneumonia in immunosuppressed patients

Respiratory isolation should be interpreted carefully because the clinical significance of an unusual Gram-negative organism depends on the specimen quality and evidence of true lower respiratory tract infection.

Diagnosis

The primary diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Blood

• Urine

• Respiratory specimens

• Wound material

• Abscess fluid

• Tissue specimens

Species identification and antimicrobial susceptibility testing are particularly useful because Kluyvera infections are uncommon.

Antimicrobial Resistance

Important Feature

The source emphasizes that information about antimicrobial susceptibility is limited.

Historically, Kluyvera species have demonstrated resistance to:

• Ampicillin

• First-generation cephalosporins

• Second-generation cephalosporins

Therefore, these agents should not automatically be assumed to provide reliable therapy.

Beta-Lactamase Significance

A particularly important microbiologic feature is that some Kluyvera species possess chromosomal beta-lactamases.

Kluyvera ascorbata is especially notable in antimicrobial-resistance microbiology because it has been recognized as a reservoir associated with the evolutionary origin of certain CTX-M-type extended-spectrum beta-lactamases (ESBLs).

This makes Kluyvera important not only as a rare pathogen but also in the study of beta-lactam resistance genes.

Treatment

The source states that several antimicrobial classes are usually active, including:

• Third-generation cephalosporins

• Antipseudomonal agents

• Fluoroquinolones

• Aminoglycosides

However, because susceptibility can vary, treatment should be based whenever possible on:

Culture + susceptibility testing

Additional Treatment

The source also lists:

Chloramphenicol

as an additional treatment option.

This represents an older therapeutic option and is not generally a preferred routine treatment when safer active alternatives are available.

Treatment Principle

Because Kluyvera infections are rare and resistance patterns can vary:

Identify the organism

↓

Perform antimicrobial susceptibility testing

↓

Determine the infection site and severity

↓

Select an active antimicrobial

↓

Provide source control when necessary

This approach is more useful than relying on a single standard regimen.

High-Yield Clinical Pattern

Immunocompromised or hospitalized patient

• ●

Bacteremia, UTI, soft-tissue infection, or pneumonia

• ●

Uncommon Gram-negative bacillus

• ●

Resistance to ampicillin/early-generation cephalosporins

→ Consider Kluyvera species

Resistance High-Yield Pattern

Kluyvera ascorbata

• ●

Chromosomal beta-lactamase

• ●

Evolutionary reservoir associated with CTX-M-type ESBL genes

→ Important connection between Kluyvera and antimicrobial resistance

Kluyvera vs. Klebsiella

Kluyvera

→ Rare opportunistic pathogen

→ Bacteremia, UTI, soft-tissue infection, pneumonia

→ Important beta-lactamase reservoir

→ Susceptibility-guided treatment

Klebsiella

→ Much more common pathogen

→ Pneumonia, UTI, bacteremia

→ Prominent polysaccharide capsule

→ Nonmotile

→ ESBL and carbapenemase resistance are major clinical concerns

Exam Essentials

Genus: Kluyvera

Important species: K. ascorbata, K. cryocrescens

Source correction: “K. cryorencens” → K. cryocrescens

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Source of infection: Frequently endogenous/opportunistic

Major infections: Bacteremia, UTI, soft-tissue infection

Important host: Immunocompromised patients

Respiratory manifestation: Pneumonia

Diagnosis: Culture

Important resistance: Ampicillin and early-generation cephalosporins may be unreliable

Important microbiology association: K. ascorbata and CTX-M-type ESBL ancestry

Potential active agents in source: Third-generation cephalosporins, fluoroquinolones, antipseudomonal agents, aminoglycosides

Historical additional treatment: Chloramphenicol

Management principle: Susceptibility-guided antimicrobial therapy

Key clinical pearl: Kluyvera species are rare opportunistic Gram-negative bacilli that can cause bacteremia, UTI, soft-tissue infection, and pneumonia. K. ascorbata is especially notable because its chromosomal beta-lactamases are linked to the evolutionary origin of important CTX-M-type ESBL resistance determinants.

Important Species The source lists: • Kluyvera ascorbata

• Kluyvera cryocrescens The source spelling “K. cryorencens” appears to be an error; the recognized species name is: Kluyvera cryocrescens

Microbiologic Characteristics Kluyvera species are: • Gram-negative bacilli

• Facultatively anaerobic members of Enterobacterales

• Generally motile

• Opportunistic pathogens

• Uncommon causes of clinically significant infection Older references may describe them simply as aerobic Gram-negative bacilli.

Incubation Period A specific incubation period is generally not applicable because infection is usually: Endogenous Disease may develop when colonizing organisms enter normally sterile sites, particularly in patients with disrupted host defenses.

Epidemiology Kluyvera species have a: Worldwide distribution However, clinically significant infection is: Rare Isolation therefore requires interpretation in the context of the patient’s symptoms, specimen source, and underlying risk factors.

Opportunistic Infection Kluyvera behaves primarily as an opportunistic pathogen. Infection is more likely in patients with: • Immunosuppression

• Serious underlying illness

• Prolonged hospitalization

• Invasive devices

• Disruption of normal anatomic barriers Nevertheless, infections can occasionally occur in otherwise healthy individuals.

Bacteremia Kluyvera species can cause: Bacteremia Bloodstream infection may arise from another focus such as the: • Urinary tract

• Soft tissues

• Respiratory tract Severe cases may progress to systemic sepsis.

High-Yield Bacteremia Pattern Hospitalized or immunocompromised patient  ●  Unusual Enterobacterales isolated from blood  ●  Possible urinary or soft-tissue source → Consider Kluyvera species

Urinary Tract Infection Kluyvera species have been associated with: Urinary tract infections Clinical presentations may include: • Cystitis

• Pyelonephritis

• Complicated urinary infection

• Urosepsis Urine culture with susceptibility testing is important because antimicrobial resistance patterns may vary.

Soft-Tissue Infection The organisms can occasionally produce: Skin and soft-tissue infection Potential manifestations include: • Wound infection

• Cellulitis

• Abscess formation Management may require both appropriate antimicrobial therapy and source control, such as drainage or debridement when indicated.

Pneumonia The source particularly associates Kluyvera with: Pneumonia in immunosuppressed patients Respiratory isolation should be interpreted carefully because the clinical significance of an unusual Gram-negative organism depends on the specimen quality and evidence of true lower respiratory tract infection.

Diagnosis The primary diagnostic method is: Culture Depending on the clinical syndrome, specimens may include: • Blood

• Urine

• Respiratory specimens

• Wound material

• Abscess fluid

• Tissue specimens Species identification and antimicrobial susceptibility testing are particularly useful because Kluyvera infections are uncommon.

Antimicrobial Resistance Important Feature The source emphasizes that information about antimicrobial susceptibility is limited. Historically, Kluyvera species have demonstrated resistance to: • Ampicillin

• First-generation cephalosporins

• Second-generation cephalosporins Therefore, these agents should not automatically be assumed to provide reliable therapy.

Beta-Lactamase Significance A particularly important microbiologic feature is that some Kluyvera species possess chromosomal beta-lactamases. Kluyvera ascorbata is especially notable in antimicrobial-resistance microbiology because it has been recognized as a reservoir associated with the evolutionary origin of certain CTX-M-type extended-spectrum beta-lactamases (ESBLs). This makes Kluyvera important not only as a rare pathogen but also in the study of beta-lactam resistance genes.

Treatment The source states that several antimicrobial classes are usually active, including: • Third-generation cephalosporins

• Antipseudomonal agents

• Fluoroquinolones

• Aminoglycosides However, because susceptibility can vary, treatment should be based whenever possible on: Culture + susceptibility testing

Additional Treatment The source also lists: Chloramphenicol as an additional treatment option. This represents an older therapeutic option and is not generally a preferred routine treatment when safer active alternatives are available.

Treatment Principle Because Kluyvera infections are rare and resistance patterns can vary: Identify the organism ↓ Perform antimicrobial susceptibility testing ↓ Determine the infection site and severity ↓ Select an active antimicrobial ↓ Provide source control when necessary This approach is more useful than relying on a single standard regimen.

High-Yield Clinical Pattern Immunocompromised or hospitalized patient  ●  Bacteremia, UTI, soft-tissue infection, or pneumonia  ●  Uncommon Gram-negative bacillus  ●  Resistance to ampicillin/early-generation cephalosporins → Consider Kluyvera species

Resistance High-Yield Pattern Kluyvera ascorbata  ●  Chromosomal beta-lactamase  ●  Evolutionary reservoir associated with CTX-M-type ESBL genes → Important connection between Kluyvera and antimicrobial resistance

Kluyvera vs. Klebsiella Kluyvera → Rare opportunistic pathogen

→ Bacteremia, UTI, soft-tissue infection, pneumonia

→ Important beta-lactamase reservoir

→ Susceptibility-guided treatment Klebsiella → Much more common pathogen

→ Pneumonia, UTI, bacteremia

→ Prominent polysaccharide capsule

→ Nonmotile

→ ESBL and carbapenemase resistance are major clinical concerns

Exam Essentials Genus: Kluyvera

Important species: K. ascorbata, K. cryocrescens

Source correction: “K. cryorencens” → K. cryocrescens

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Source of infection: Frequently endogenous/opportunistic

Major infections: Bacteremia, UTI, soft-tissue infection

Important host: Immunocompromised patients

Respiratory manifestation: Pneumonia

Diagnosis: Culture

Important resistance: Ampicillin and early-generation cephalosporins may be unreliable

Important microbiology association: K. ascorbata and CTX-M-type ESBL ancestry

Potential active agents in source: Third-generation cephalosporins, fluoroquinolones, antipseudomonal agents, aminoglycosides

Historical additional treatment: Chloramphenicol

Management principle: Susceptibility-guided antimicrobial therapy

Key clinical pearl: Kluyvera species are rare opportunistic Gram-negative bacilli that can cause bacteremia, UTI, soft-tissue infection, and pneumonia. K. ascorbata is especially notable because its chromosomal beta-lactamases are linked to the evolutionary origin of important CTX-M-type ESBL resistance determinants.